Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum.
about
Ecstasy: are animal data consistent between species and can they translate to humans?Developmental effects of 3,4-methylenedioxymethamphetamine: a reviewN-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin TransportersCauses and consequences of methamphetamine and MDMA toxicity.Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosteroneThe role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.Oxidative stress in rat kidneys due to 3,4-methylenedioxymetamphetamine (ecstasy) toxicity.Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation.
P2860
Q31033315-07C0DAA6-D7B2-42EA-AEC9-A920E9D6EFF3Q33923930-91EEC193-E20D-4282-BCD0-8B223D841F44Q34360861-A798F4F5-1267-4C7D-9966-D5F47349200BQ35107898-388D06DD-2DD3-4800-BDC4-CBDF3EF92569Q35594881-0D8F33EB-4132-4B91-86CD-082AF6C48AD3Q37012610-0AE08F58-CACB-4E00-983A-20CFF16FDC18Q37180812-76208D62-76E9-46B6-BEA3-E1608970C64AQ37245998-2B4D0D29-C5C0-4511-A3FC-FEA94EE1CADAQ37870701-85326EC3-3D9E-4A2F-96F7-2B9D993A6961Q38048826-ED6E7F7B-4584-4BEC-8738-8A0933AE62CAQ38758177-35467F1D-90E8-4B34-8D37-B8357315B334Q43543985-99D6FED7-8BD3-4B63-9C6A-37BEB5FB74A1Q44028686-3C8A80CF-F9A6-41E5-8B18-45D1E18CB6B1Q46805472-FAC04DBC-882C-4DED-9DFC-835A7B2D4307Q46970772-5A886950-03DD-49D8-A6FF-DE14F1BC07CAQ55043421-29E55A57-BC38-4539-B40D-7952888B15B8
P2860
Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@en
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@nl
type
label
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@en
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@nl
prefLabel
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@en
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@nl
P2093
P2860
P1476
Mazindol attenuates the 3,4-me ...... of serotonin in the striatum.
@en
P2093
Gudelsky GA
Shankaran M
Yamamoto BK
P2860
P304
P356
10.1046/J.1471-4159.1999.0722516.X
P407
P577
1999-06-01T00:00:00Z